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This study identifies the eﬀects of sleep restriction and subsequent recovery sleep on glucose homeostasis, serum leptin levels, and
feelings of subjective satiety. Twenty-three healthy young men were allocated to a control group (CON) or an experimental (EXP)
group. After two nights of 8 h in bed (baseline, BL), EXP spent 4 h in bed for five days (sleep restriction, SR), followed by two nights
of 8 h (recovery, REC). CON spent 8 h in bed throughout the study. Blood samples were taken after the BL, SR, and REC period. In
EXP, insulin and insulin-to-glucose ratio increased after SR. IGF-1 levels increased after REC. Leptin levels were elevated after both
SR and REC; subjective satiety remained unaﬀected. No changes were observed in CON. The observed increase of serum IGF-1
and insulin-to-glucose ratio indicates that sleep restriction may result in an increased risk to develop type 2 diabetes.
1. Introduction
Sleep is considered to be a restorative process with beneficial
eﬀects on many bodily systems, including the digestive
system, the immune system, and the cardiovascular system.
Yet in modern industrialized societies, voluntary restriction
of sleep is getting increasingly common due to, for instance,
increasing work demands and atypical working hours [1].
Moreover, partial loss of sleep is common among people
who experience environmental or psychological stress, who
have psychiatric or physical disorders or who participate in
shift work [2]. The consequences of this chronic deficiency
of sleep are numerous and include increasing amounts of
accidents, both in traﬃc and at work, increased prevalence
of certain diseases, and even increased mortality [2]. It
is important to understand and elucidate the mechanisms
through which sleep and health are related if we are to find
ways to manage people with chronically restricted sleep.
Suﬃcient sleep is a key component in the regulation
of energy metabolism. Several epidemiological studies have
shown that habitual short sleep duration is correlated with
an increased risk of developing obesity and diabetes [3, 4].
Controlled laboratory studies, investigating the eﬀects of
prolonged sleep restriction on energy metabolism, are more
scarce. Glucose tolerance has been shown to be impaired
after six days of sleep restricted to four hours per night,
compared to a condition in which participants were allowed
twelve hours in bed per night for six days [5], which
might contribute to the risk of developing type 2 diabetes.
Furthermore, it has been shown that two nights of sleep
restricted to four hours, compared to two nights of ten
hours in bed, results in a reduction of the satiety hormone
leptin, accompanied by increased hunger and increased
serum concentrations of the orexigenic factor ghrelin [6],
which might add to the risk of developing obesity.
Rodent studies on energy metabolism have mainly
applied either a total sleep deprivation or a selective REM
sleep deprivation design, which are both diﬃcult to compare
to a sleep restriction design. Everson and Crowley showed, in
rats, that 15 days of sleep restriction suppress concentrations
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of IGF-1 and leptin [7], which was, interestingly, accompa-
nied by weight loss. Bodosi and colleagues have shown, on
the other hand, that 5 h sleep deprivation does not aﬀect
leptin concentrations but increases ghrelin concentrations
[8].
In the present study, we simulated accumulating sleep
restriction during five working days followed by two days of
weekend recovery sleep and measured the changes in several
metabolic parameters that occurred during this period,
including glucose metabolism, serum leptin concentrations,
and feelings of satiety.
2. Materials and Methods
2.1. Participants. Twenty-three healthy men, aged 19–29
(mean ± SD 23.1 ± 2.5), participated in this study and
were recruited by advertisements in local newspapers dur-
ing a two-year time span. First, volunteers were screened
during a telephone interview, followed by a thorough
physical examination, blood tests (triglycerides, cholesterol,
haemoglobin, creatinine, leukocytes, erythrocytes, haemat-
ocrit, TSH, ASAT, ALAT, MCV, MCH, and MCHC), and
screening polysomnography. Participants’ final eligibility
was evaluated according to preset inclusion and exclusion
criteria. Volunteers were excluded from participation for
any of the following: an irregular sleep-wake schedule,
regular naps, having either advanced or delayed sleep
phase syndrome, insomnia or other sleep problems, loud
snoring >5 nights/week, repeating apneas, excessive daytime
sleepiness (Epworth Sleepiness Scale >8), restless legs at
least once a month, a disorder that might become worse
because of prolonged wakefulness (such as a severe mental
disorder, epilepsy, and cardiac arrhythmia), excessive caﬀeine
consumption (>5 cups of coﬀee/day), excessive alcohol
consumption (>15 units/week; 1 unit = 11 g or 13.9 mL of
alcohol), smoking, medication aﬀecting the central nervous
system during the last two weeks, any clinically relevant
abnormality on blood tests, any other reason that health
may be harmed because of if participating, apnea-hypopnea
index >20, periodic limb movement index >25, epileptiform
activity on the EEG, abnormal urinary drug screening, and
having experienced a significant recent life event that could
disturb sleep. In addition, volunteers were only included
when fulfilling all of the following criteria: male aged 19–29,
sleep latency in the evening <20–30 minutes, uninterrupted
nocturnal sleep and if awakened no problem to fall asleep
again, no chronic disease or symptom aﬀecting sleep, no
continuous medication, and willing and able to participate.
All participants reported habitual sleep duration of 7–
9 hours and a regular sleep-wake schedule. For at least one
week prior to the experiment they completed sleep diaries
and carried actigraphs in order to verify adherence to a
regular sleep-wake schedule. One week prior to the start of
the experiment, participants had an adaptation night in the
sleep laboratory. The prestudy mean (±SD) sleep duration
was 6.88 (±0.58) h in the control group and 7.05 (±0.80) h in
the experimental group. Participant’s prestudy mean (±SD)
body mass index (BMI) was 23.24 (±2.39) in the control
group and 23.25 (±2.70) in the experimental group.
2.2. Experimental Protocol. The protocol was approved by
the ethical committee of the University Hospital of Helsinki
District, and written confirmed consent was obtained from
all participants. A 10-day experimental schedule (Figure 1)
was executed at the Brain and Work Research Centre of
the Finnish Institute of Occupational Health (FIOH). Alto-
gether, participants spent ten consecutive nights in the sleep
laboratory. Fifteen participants were randomly allocated to
the experimental group (EXP), spent the first two nights
8 h in bed (baseline, BL; from 23:00 h to 07:00 h), followed
by five nights of 4 h in bed (sleep restriction, SR; from
03:00 h to 07:00 h) and, finally, again three nights of 8 h
in bed (recovery, REC). Eight participants were randomly
allocated to the control group (CON) and spent 8 h in
bed every night. Sleep during the daytime was not allowed,
which was monitored by EEG recordings and a continuously
present investigator. During waking, participants took part
in a bigger experiment of our sleep laboratory involving
the simulation of a workweek by a variety of cognitive
and psychological tasks. Their main activities during the
day included the repeated assessment of the psychomotor
vigilance task (PVT), the Brain@Work Multitask, a saccade
test, and the training and testing of memory and motor tasks.
Moreover, saliva samples were provided ten times per day
and blood pressure was assessed eight times a day.
Participants ate standardized meals at fixed times
throughout the experiment: breakfast at 08:00 h (600 kcal),
lunch at 12:30 h (800 kcal), dinner at 18:30 h (700 kcal);
snacks at 15:30 h (300 kcal) and 21:30 h (200 kcal). In
addition, participants in EXP ate a piece of fruit (apple or
orange) at 00:30 h (50 kcal). Participants were not allowed
to leave the building but could, during regular short breaks,
leave the sleep and test room and visit a relax room with
television and PC. Illuminance in the sleep and test room
ranged from 150 to 400 lux, and in the relax room from 350
to 600 lux, the temperature in the rooms ranged from 19 to
23 degrees Celsius. Polygraphy and ECG were continuously
measured.
2.3. HormonalMeasurements. Hormonal levels were assessed
from blood samples that were taken before breakfast at
07:30 h after the second BL night, the fifth SR night, and
the second REC night in EXP and corresponding nights
in CON. Samples were analyzed by Medix Laboratories,
Espoo, Finland for glucose, insulin, IGF1, and leptin. Before
blood sampling, subjects were asked to rate their feeling of
hungriness on a 1 to 5 scale (1 = very hungry, 5 = very
satiated). The saliva samples described above were analyzed
for cortisol levels using a commercial kit assay (Salivary
Cortisol, LIA, IBL, Hamburg, Germany).
2.4. Statistical Analysis. For both CON and EXP, mean
values ± SD were calculated for each experimental day,
BL, SR, and REC. In addition, SR and REC values were
expressed as percentages of each individual participant’s
BL value, that is, normalized. We have compared SR and
REC values to BL values by applying paired t-tests for
normally distributed diﬀerences and Wilcoxon signed ranks
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Figure 1: The experimental protocol. After two nights of 8 h sleep
(baseline BL), sleep is restricted to 4 h per night for 5 subsequent
days (sleep restriction, SR), followed by three nights of 8 h recovery
sleep (REC). Profile days are shaded in grey. Bullet points indicate
the taking of blood samples and rating of subjective satiety.
tests for diﬀerences that were not normally distributed. The
normality of diﬀerences was checked using Kolmogorov-
Smirnov goodness of fit test. A P-value <.05 was considered
to be statistically significant. All statistical analyses were
carried out using SPSS version 15 (SPSS Inc., Chicago, USA).
3. Results
3.1. Total Sleep Duration and Cortisol Profile. In CON,
the mean total sleep duration (±SD) remained unaﬀected
throughout the experiment, whereas in EXP, the mean sleep
duration, as expected, strongly reduced during the SR period
(Table 1). In EXP, the peak in cortisol levels was delayed with
16.2 ± 5.5 min. after SR compared to BL (P < .05; Table 1).
After REC, the cortisol profile was similar to BL again. In
CON, the cortisol profile remained unaﬀected throughout
the experiment (Table 1).
3.2. Glucose, Insulin, and IGF-1. Mean glucose, insulin, and
IGF-1 levels throughout the experiment in both groups are
described in Table 2. Glucose levels showed a tendency for a
decrease after SR and its levels were significantly decreased
after REC to 65.5% ± 1.3% of BL levels (P < .05; Figure 2).
In CON, glucose levels remained at BL level throughout the
experiment (Figure 2).
Insulin levels were increased after SR to 159.9% ± 25.6%
of BL levels (P < .05; Figure 2) and returned back to BL
levels after recovery (114.5% ± 10.1% of BL levels). In
CON, insulin levels remained at BL level throughout the
experiment (Figure 2).
The insulin-to-glucose ratio was significantly increased
after SR to 160.8% ± 25.4% of BL levels (P < .05; Figure 2),
returning back to BL levels after subsequent REC
(118.2% ± 9.9% of BL levels). In CON, the insulin-to-
glucose ratio remained at BL level throughout the experi-
ment (Figure 2).
IGF-1 levels showed a tendency for an increase after
SR and its levels were significantly elevated after REC to
111.7% ± 3.6% of BL levels (P < .01). In CON, IGF-1 levels
remained at BL level throughout the experiment (Figure 2).
3.3. Leptin and Subjective Satiety. Mean leptin levels and
feelings of subjective satiety throughout the experiment
in both groups are described in Table 2. Leptin levels
were increased after SR to 163.3% ± 42.4% of BL levels
(P < .01) and were still significantly elevated after REC
(123.1% ± 7.0% of BL levels; P < .01; Figure 2). In CON,
leptin levels remained at BL level throughout the experiment
(Figure 2).
Feelings of satiety remained unaﬀected throughout the
experiment in both groups (Figure 2).
4. Discussion
Chronic sleep deprivation is becoming an increasingly
common phenomenon in modern 24 h societies due to,
for instance, voluntary sleep restriction and increasing
work demands [1, 9]. Restricted sleep does not only result
in sleepiness and impaired cognitive performance, it also
adversely aﬀects general health [10]. Several widespread dis-
orders have been shown to be epidemiologically associated
with habitual short sleep duration, including cardiovascular
diseases [11, 12], type 2 diabetes [13], and obesity [14, 15].
In the present study, serum glucose levels declined during
the course of sleep restriction and subsequent recovery
sleep, whereas serum insulin levels increased. Hence, the
insulin-to-glucose ratio was significantly elevated after sleep
restriction but returned to baseline values after subsequent
recovery sleep. Elevating insulin levels that are not accom-
panied by elevations in glucose levels indicate a reduced
sensitivity to insulin, which may ultimately increase the risk
of developing noninsulin-dependent diabetes (i.e., type 2
diabetes). Taken together with a previous study showing
that prolonged sleep restriction significantly lowers glucose
tolerance [5], the experimental support for a causative
connection between insuﬃcient sleep and type 2 diabetes
is gradually accumulating and supports the already present
epidemiological evidence [13, 16, 17].
Under normal physiological conditions, blood glucose
concentrations are tightly regulated within narrow limits. A
well-known condition in which blood glucose levels rise due
to deficits in insulin signaling is diabetes, but no common
conditions are known in which blood glucose levels decline.
Blood glucose is the most important energy supply to the
brain and, therefore, the observed decrease in glucose after
recovery as compared to baseline is as puzzling as it is
alarming, since the most important adverse eﬀect of chroni-
cally decreased blood glucose levels is brain dysfunction and
in extreme cases even damage [18]. Moreover, low levels
of fasting blood glucose are associated with an increased
mortality risk [19].
In addition to insulin, insulin-like growth factor-1 (IGF-
1) is another substance that lowers serum levels of glucose in
both rats and humans [20, 21] and has even the capability
of doing so in patients with severe insulin resistance [22].
The present study has indeed shown that, after recovery, IGF-
1 levels were increased while glucose levels were decreased.
Interestingly, in addition to lowering serum glucose levels,
IGF-1 has also been shown to decrease serum insulin levels in
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Figure 2: Changes in serum concentrations of leptin, IGF-1, insulin, and glucose, and changes in insulin-to-glucose ratio and subjective
satiety after sleep restriction (SR) and recovery (REC) in the control group (CON) and experimental group (EXP). Data are expressed as
percentages of participant’s individual baseline values (mean ± SEM) (∗P < .05).
both rats and humans [23, 24]. It has been hypothesized that,
by lowering insulin levels, IGF-1 reduces insulin resistance
and might thus be of therapeutical importance in physio-
logical states that are associated with insulin resistance, such
as type 2 diabetes. Hence, the observed elevations in IGF-
1 after recovery in the present study might be viewed as
a compensatory reaction to the increased insulin levels after
sleep restriction.
The rapidly expanding global incidence of obesity has a
great impact on public health [25], for instance, by increasing
the risk of developing cardiovascular diseases. Not only has
this trend been paralleled by a trend of a gradual reduction
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Table 1: Sleep duration and cortisol.
Variable Group
Day
BL SR REC
Mean (±SD) Mean (±SD) Mean (±SD)
Total sleep duration (min.)
CON 440 (±23) 442 (±16) 429 (±27)
EXP 439 (±20) 232 (±5) 458 (±13)
Cortisol peak (clock time)
CON 07:48 (±0:15) 07:33 (±0:19) 07:33 (±0:10)
EXP 07:39 (±0:14) 07:55 (±0:11) 07:36 (±0:13)
Table 2: Descriptives of the data.
Variable Group
Day
BL SR REC
Mean (±SD) Mean (±SD) Mean (±SD)
Glucose (mmol/L)
CON 5.14 (±0.50) 5.13 (±0.49) 5.04 (±0.41)
EXP 4.91 (±0.24) 4.83 (±0.24) 4.74 (±0.17)
Insulin (mU/L)
CON 8.27 (±2.62) 7.33 (±2.84) 7.50 (±2.82)
EXP 6.02 (±2.90) 8.59 (±6.99) 6.25 (±2.36)
Insulin-to-glucose ratio
CON 1.65 (±0.65) 1.49 (±0.73) 1.52 (±0.67)
EXP 1.22 (±0.57) 1.75 (±1.33) 1.31 (±0.46)
IGF-1 (nmol/L)
CON 33.81 (±11.15) 34.84 (±10.99) 34.03 (±11.63)
EXP 26.35 (±6.29) 27.64 (±5.39) 28.93 (±5.23)
Leptin (µg/L)
CON 3.44 (±3.09) 3.79 (±2.92) 3.70 (±2.80)
EXP 6.25 (±4.55) 7.59 (±5.00) 6.93 (±4.07)
Satiety (1 to 5 scale)
CON 2.71 (±0.76) 2.57 (±0.98) 2.57 (±0.98)
EXP 2.21 (±0.43) 1.79 (±0.70) 2.00 (±0.55)
in self-reported sleep duration, many epidemiological studies
have linked those trends and observed a correlation between
short sleep and obesity [26]. Recently, however, several
groups have questioned the clinical relevance of this link
[27, 28]. Expanding the current literature with experimental
investigations might attribute to resolving those heated
debates, editorials, and news reports.
Leptin and ghrelin are peripheral hormones believed to
contribute to the central regulation of food intake [29].
Ghrelin, predominantly released by the stomach, stimulates
appetite whereas leptin, mainly produced by adipocytes,
stimulates feelings of satiety. Therefore, chronic elevations of
ghrelin levels and/or reductions of leptin levels may attribute
to the development of obesity. Obesity is indeed associated
with leptin resistance and obese subjects show highly ele-
vated serum concentrations of leptin [30]. Hitherto, only
two experimental studies have investigated the eﬀects of
prolonged sleep restriction on serum ghrelin and leptin levels
and observed decreased leptin and increased ghrelin levels,
accompanied by increased feelings of hunger and appetite
after a period of 4 h sleep compared to a period of 10 h
sleep [6] and 12 h sleep [31]. In addition, prolonged sleep
restriction in rats has been shown to result in decreased leptin
levels that were associated with a reduction in body weight
despite an increase in food intake [7]. Our observations,
interestingly, contradict those findings in not having found
any changes in feelings of hunger and having found an
increase rather than a decrease in serum leptin levels.
Several factors are known to regulate serum leptin
concentrations. Taheri and colleagues have shown that sleep
duration is correlated to leptin levels [32]. Hence, long-
sleepers have higher serum leptin concentrations than short-
sleepers. We are, however, the first to show in a within-
subject design that experimental restriction of participant’s
habitual sleep duration does not have a similar eﬀect and that
it is even increasing serum leptin concentrations. The only
previous experimental studies compared sleep restriction
against sleep extension and have found that after sleep
restriction, leptin levels are lower than after sleep extension
but unaﬀected as compared to participant’s habitual sleep
duration [6, 31].
Serum leptin concentrations are known to exhibit a
circadian rhythm, with minimum values during daytime
and a nocturnal rise [33]. This rhythm is not entrained to
the circadian clock, but to meal patterns [34]. However, it
does not acutely change in response to single meals [35]: a
substantial meal of 1000 kcal did not alter leptin levels for
the next three hours after administration [36]. In our study,
there was only a modest (16 minute) delay in the endogenous
circadian rhythm of salivary cortisol in the experimental
group. However, meal timing was kept constant throughout
the experiment, except for an additional apple or orange that
participants in the experimental group received at 00:30 h
during the days of restricted sleep. We find it unlikely that
this small addition of about 50 kcal for a period of five days
to the habitual meal pattern would have increased leptin
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levels with 63%. How abolishing oral meals completely by
replacing them with intravenous glucose infusion aﬀects
serum leptin concentrations [6] is not known.
Physical activity is inversely related to fasting plasma
leptin levels [37]. Physical exercise has indeed been shown
to result in decreased concentrations of serum leptin, both
acutely and over the entire 24 h time span [38, 39]. In the
present study, however, we did not aim to keep physical
activity constant. Hence, participants in the experimental
group were not restricted in their physical activity during the
period of prolonged wakefulness. Therefore, physical activity
was slightly elevated during this period when compared to
the baseline and recovery periods. This could, in theory, have
decreased leptin levels.
Leptin has for a long time been considered to be purely
a satiety signal and previous sleep restriction studies have
indeed found that lower leptin levels were associated with
increased feelings of hunger [6]. In the present study,
however, elevated leptin levels were not accompanied by any
changes in hunger feelings. This may suggest that leptin plays
additional physiological roles apart from regulating food
intake, such as a proinflammatory role [40, 41].
An alternative explanation for the observed epidemio-
logical correlation between short sleep and obesity might
have little to do with the homeostatic control of sleeping and
feeding behavior. As Saper and colleagues have pointed out,
both the regulation of feeding and sleeping have a strong
hedonic component [42, 43]. That is, both can be very
satisfying at times when their physiological need is not that
strong. It may be that, under the unpleasant experience of
restricted sleep, a search for pleasure begins and excessive
food is being consumed. Indeed, it has been shown that
sleep restricted subjects—in a setting of ad libitum access to
palatable food—consume excessive amounts of calories from
snacks [44].
5. Conclusions
We showed that prolonged sleep restriction in a situation
that mimics a working week changes glucose metabolism and
may lead to an increased risk of developing type 2 diabetes.
Two nights of normal sleep, however, restored this eﬀect.
In addition, we showed that five nights of sleep restriction
does not aﬀect hunger feelings and results in elevated leptin
levels. This suggests that sleep restriction per se as it would
occur during a typical working week may not increase the
risk of developing obesity. Therefore, the previously observed
epidemiological associations between short sleep and obesity
might be due to a common underlying factor rather than a
direct causation between short sleep and obesity. In addition,
the excessive consumption of calories from snacks rather
than from meals during a period of restricted sleep may
contribute to the development of weight gain and/or obesity
[44].
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